Affordable Access

deepdyve-link deepdyve-link
Publisher Website

The combined effect of survivin-targeted shRNA and emodin on the proliferation and invasion of ovarian cancer cells.

Authors
Type
Published Article
Journal
Anti-Cancer Drugs
0959-4973
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Volume
24
Issue
9
Pages
937–944
Identifiers
DOI: 10.1097/CAD.0b013e328364efe0
PMID: 23921083
Source
Medline

Abstract

Statistics

Seen <100 times